mimmunМедицинская иммунологияMedical Immunology (Russia)1563-06252313-741XSPb RAACI10.15789/1563-0625-2010-1-2-115-124mimmun-52Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESПОЛНОРАЗМЕРНЫЙ ПЕПТИДНЫЙ АНАЛИЗ АНТИГЕННОГО ПРОФИЛЯ ПОВЕРХНОСТНЫХ БЕЛКОВ СИБИРСКИХ ИЗОЛЯТОВ ВИРУСА ГЕПАТИТА CFULL-LENGTH PEPTIDE ASSAY OF ANTIGENIC PROFILE OF ENVELOPE PROTEINS FROM SIBERIAN ISOLATES OF HEPATITIS C VIRUSГражданцеваА. А.GrazhdantsevaA. A.СиволобоваГ. Ф.SivolobovaG. F.MajorM.MajorM.ЧубЕ. В.ChubE. V.ШваловА. Н.ShvalovA. N.ЮдинП. В.YudinP. V.НетесовС. В.NetesovS. V.ЛоктевВ. Б.LoktevV. B.КочневаГ. В.KochnevaG. V.ФГУН Государственный научный центр вирусологии и биотехнологии «Вектор» Роспотребнадзора,
Новосибирская обл., г. КольцовоРоссияЦентр по оценке и исследованиям биологических препаратов, Управление по контролю за пищевыми продуктами и лекарственными средствами США, Мэриленд, г. БетездаРоссияФГУН Государственный научный центр вирусологии и биотехнологии «Вектор» Роспотребнадзора,
Новосибирская обл., г. Кольцово
ГОУ ВПО «Новосибирский государственный университет», г. НовосибирскРоссия201010072014121-2115124Copyright © Гражданцева А.А., Сиволобова Г.Ф., Major M., Чуб Е.В., Швалов А.Н., Юдин П.В., Нетесов С.В., Локтев В.Б., Кочнева Г.В., 20142014Гражданцева А.А., Сиволобова Г.Ф., Major M., Чуб Е.В., Швалов А.Н., Юдин П.В., Нетесов С.В., Локтев В.Б., Кочнева Г.В.Grazhdantseva A.A., Sivolobova G.F., Major M., Chub E.V., Shvalov A.N., Yudin P.V., Netesov S.V., Loktev V.B., Kochneva G.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.mimmun.ru/mimmun/article/view/52вирус гепатита Сгенотиппептидный анализантигенная детерминантаhepatitis C virusgenоtypepeptide analysisantigenic determinantReferencesШустов А.В., Кочнева Г.В., Сиволобова Г.Ф., Гражданцева А.А., Гаврилова И.В., Нестеров А.Е., Стрельцова М.А., Пальцев А.И., Локтев А.В., Максютов А.З., Акинфеева Л.А., Торшин В.П., West T.E., Ryder R.W., Онищенко Г.Г. Частота встречаемости маркеров гепатита С и факторы риска у персонала больниц Новосибирской области // Журн. микробиол. эпидемиол. и иммунобиологии (ЖМЭИ). -2002. -T. 2. - C. 26-32.Шустов А.В., Кочнева Г.В., Сиволобова Г.Ф., Гражданцева А.А., Гаврилова И.В., Нестеров А.Е., Стрельцова М.А., Пальцев А.И., Локтев А.В., Максютов А.З., Акинфеева Л.А., Торшин В.П., West T.E., Ryder R.W., Онищенко Г.Г. Частота встречаемости маркеров гепатита С и факторы риска у персонала больниц Новосибирской области // Журн. микробиол. эпидемиол. и иммунобиологии (ЖМЭИ). -2002. -T. 2. - C. 26-32.Bowen D.G., Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection // Nature. -2005. -Vol. 436. -P. 946-952.Bowen D.G., Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection // Nature. -2005. -Vol. 436. -P. 946-952.Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes // Semin Liver Dis. -1995. -Vol. 15. -P. 41-63.Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes // Semin Liver Dis. -1995. -Vol. 15. -P. 41-63.Carlos M.P., Yamamura Y., Vu Q., Conzen K., Anderson D.E., Torres J.V. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b // Clin. Immunol. -2004. -Vol. 111. -P. 22-27.Carlos M.P., Yamamura Y., Vu Q., Conzen K., Anderson D.E., Torres J.V. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b // Clin. Immunol. -2004. -Vol. 111. -P. 22-27.Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H., Purcell R. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein // Proc. Natl. Acad. Sci. USA. -1996. -Vol. 93. -P. 15394-15399.Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H., Purcell R. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein // Proc. Natl. Acad. Sci. USA. -1996. -Vol. 93. -P. 15394-15399.Gotto J., Dusheiko G.M. Hepatitis C and treatment with pegylated interferon and ribavirin // Int. J. Biochem. Cell Biol. -2004. -Vol. 36, N 10. -P. 1874-1877.Gotto J., Dusheiko G.M. Hepatitis C and treatment with pegylated interferon and ribavirin // Int. J. Biochem. Cell Biol. -2004. -Vol. 36, N 10. -P. 1874-1877.Ishida C., Matsumoto K., Fukada K., Matsushita K., Shiraki H., Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens // J. Clin. Microbiol. -1993. -Vol. 31. -P. 936-940.Ishida C., Matsumoto K., Fukada K., Matsushita K., Shiraki H., Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens // J. Clin. Microbiol. -1993. -Vol. 31. -P. 936-940.Keck Z-Y., Sung V.M.H., Perkins S., Rowe J., Paul S., Liang T.J., Lai M.M.C., Foung S.K.H. Human monoclonal antibody to hepatitis C Virus E1 glycoprotein that blocks virus attachment and viral infectivity//J. Virol. -2004. -Vol. 78, N 13. -P. 7257-7263.Keck Z-Y., Sung V.M.H., Perkins S., Rowe J., Paul S., Liang T.J., Lai M.M.C., Foung S.K.H. Human monoclonal antibody to hepatitis C Virus E1 glycoprotein that blocks virus attachment and viral infectivity//J. Virol. -2004. -Vol. 78, N 13. -P. 7257-7263.Lecnmann M., Ihlenfeldt H.G., Braunschweiger I., Gierls G., Jung G., Matz B., Kaiser R., Sauberbruch T., Spengler U. T and B Cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia // Hepatology. -1996. -Vol. 24, N 4. -P. 790-795.Lecnmann M., Ihlenfeldt H.G., Braunschweiger I., Gierls G., Jung G., Matz B., Kaiser R., Sauberbruch T., Spengler U. T and B Cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia // Hepatology. -1996. -Vol. 24, N 4. -P. 790-795.Martinez-Donato G., Duenas-Carrera S., Alvarez-Lajonchere L., Morales J., Acosta-Rivero N., Martínez E., Viña A., Guerra I., Prez A., Musacchio A., García J., Reyes O., Garay H.E., González L.J., Alvarez J.C., Soria Y. Antigenicity and immunogenecity of the hepatitis C virus envelope E2 protein // Biotecnologia Aplicada. -2006. -Vol. 23, N 1. -P. 60-63.Martinez-Donato G., Duenas-Carrera S., Alvarez-Lajonchere L., Morales J., Acosta-Rivero N., Martínez E., Viña A., Guerra I., Prez A., Musacchio A., García J., Reyes O., Garay H.E., González L.J., Alvarez J.C., Soria Y. Antigenicity and immunogenecity of the hepatitis C virus envelope E2 protein // Biotecnologia Aplicada. -2006. -Vol. 23, N 1. -P. 60-63.Meunier J.C., Russell R.S., Goossens V., Priem S., Walter H., Depla E., Union A., Faulk K.N., Bukh J., Emerson S.U., Purcell R.H. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus // J. Virol. -2008. -Vol. 82, N 2. -P. 966-973.Meunier J.C., Russell R.S., Goossens V., Priem S., Walter H., Depla E., Union A., Faulk K.N., Bukh J., Emerson S.U., Purcell R.H. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus // J. Virol. -2008. -Vol. 82, N 2. -P. 966-973.Olenina L.V., Nikolaeva L.I., Sobolev B.N., Blokhina N.P., Archakov A.I., Kolesanova E.F. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins // J. Viral. Hepat. -2002. -Vol. 9. -P. 174-182.Olenina L.V., Nikolaeva L.I., Sobolev B.N., Blokhina N.P., Archakov A.I., Kolesanova E.F. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins // J. Viral. Hepat. -2002. -Vol. 9. -P. 174-182.Perotti M., Mancini N., Diotti R.A., Tarr A.W., Ball J.K., Owsianka A., Adair R., Patel A.H., Clementi M., Burioni R. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein // J. Virol. -2008. -Vol. 82, N 2. - P. 1047-1052.Perotti M., Mancini N., Diotti R.A., Tarr A.W., Ball J.K., Owsianka A., Adair R., Patel A.H., Clementi M., Burioni R. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein // J. Virol. -2008. -Vol. 82, N 2. - P. 1047-1052.Petit M.-A., Jolivet-Reynaud C., Peronnet E., Michal Y., Tre'po C. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope // J. Biol. Chem. -2003. -Vol. 278, N 45. -P. 44385-44392.Petit M.-A., Jolivet-Reynaud C., Peronnet E., Michal Y., Tre'po C. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope // J. Biol. Chem. -2003. -Vol. 278, N 45. -P. 44385-44392.Petrik J., Alexander G.J.M., Pearson G., Allain J.P. Reactivity of synthetic peptides representing selected sections of hepatitis C virus Core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma//J. Med. Virol. -1997. -Vol. 51. -P. 67-79.Petrik J., Alexander G.J.M., Pearson G., Allain J.P. Reactivity of synthetic peptides representing selected sections of hepatitis C virus Core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma//J. Med. Virol. -1997. -Vol. 51. -P. 67-79.Sallberg M., Ruden U., Wahren B., Magnius L.O. Antigenic regions within the hepatitis C virus envelope 1 and structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein // Clin. Exp. Imunol. -1993. -Vol. 91. -P. 489-494.Sallberg M., Ruden U., Wahren B., Magnius L.O. Antigenic regions within the hepatitis C virus envelope 1 and structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein // Clin. Exp. Imunol. -1993. -Vol. 91. -P. 489-494.Seeff L.B. Natural history of chronic hepatitis C // Hepatology. -2002. -Vol. 36, N 5. - P. 35-46.Seeff L.B. Natural history of chronic hepatitis C // Hepatology. -2002. -Vol. 36, N 5. - P. 35-46.Shimizu Y.K., Igarashi H., Kiyohara T. A hyperimmune constructs against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures // Virol. -1996. -Vol. 223. -P. 409-412.Shimizu Y.K., Igarashi H., Kiyohara T. A hyperimmune constructs against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures // Virol. -1996. -Vol. 223. -P. 409-412.Simmonds P., Rose K.A., Graham S., Chan S.W., McOmish F., Dow B.C., Follet E.A., Yap P.L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 // J. Clin. Microbiol. -1993. -Vol. 31. -P. 1493-1503.Simmonds P., Rose K.A., Graham S., Chan S.W., McOmish F., Dow B.C., Follet E.A., Yap P.L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 // J. Clin. Microbiol. -1993. -Vol. 31. -P. 1493-1503.Simmonds P. The origin and evolution of hepatitis viruses in humans // J. Gen. Virol. -2001. -Vol. 82. -P. 693-712.Simmonds P. The origin and evolution of hepatitis viruses in humans // J. Gen. Virol. -2001. -Vol. 82. -P. 693-712.Tarr A.W., Owsianka A.M., Timms J.M., Patrick McClure C., Brown R.J.P., Hickling T.P., Pietschmann T., Bartenschlager R., Patel A.H., Ball J.K. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 // Hepatology. -2006. -Vol. 43, N 3. -P. 592-601.Tarr A.W., Owsianka A.M., Timms J.M., Patrick McClure C., Brown R.J.P., Hickling T.P., Pietschmann T., Bartenschlager R., Patel A.H., Ball J.K. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 // Hepatology. -2006. -Vol. 43, N 3. -P. 592-601.Tarr A.W., Owsianka A.M., Szwejk A., Ball J.K., Patel A.H. Cloning, expression and functional analysis of patient-derived hepatitis C virus glycoproteins // Methods Mol. Biol. -2007. -Vol. 379. -P. 177-197.Tarr A.W., Owsianka A.M., Szwejk A., Ball J.K., Patel A.H. Cloning, expression and functional analysis of patient-derived hepatitis C virus glycoproteins // Methods Mol. Biol. -2007. -Vol. 379. -P. 177-197.Tarr A.W., Owsianka A.M., Jayaraj D., Brown R.J.P., Hickling T.P., Irving W.L., Patel A.H., Ball J.K. Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 // J. Gen. Virol. -2007. -Vol. 88. -Р. 2991-3001.Tarr A.W., Owsianka A.M., Jayaraj D., Brown R.J.P., Hickling T.P., Irving W.L., Patel A.H., Ball J.K. Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 // J. Gen. Virol. -2007. -Vol. 88. -Р. 2991-3001.Zhang Z.-X., Sonnerborg A., Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein // Clin. Exp. Immunol. -1994. -Vol. 98. -P. 382-387.Zhang Z.-X., Sonnerborg A., Sallberg M. Antigenic structure of the hepatitis C virus envelope 2 protein // Clin. Exp. Immunol. -1994. -Vol. 98. -P. 382-387.Zang P., Wu C.G., Mihalik K., Virata-Theimer M.L., Yu M.W., Alter H.J., Feinstone S.M. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma // Proc. Natl. Acad. Sci. USA. -2007. -Vol. 104, N 20. -P. 8449-8454.Zang P., Wu C.G., Mihalik K., Virata-Theimer M.L., Yu M.W., Alter H.J., Feinstone S.M. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma // Proc. Natl. Acad. Sci. USA. -2007. -Vol. 104, N 20. -P. 8449-8454.Zhang P., Zhong L., Struble E. B., Watanabe H., Kachko A., Mihalik K., Virata-Theimer M.L., Alter H.J., Feinstone S., Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity // Proc. Natl. Acad. Sci. USA. -2009. -Vol. 106, N 18. -P. 537-541.Zhang P., Zhong L., Struble E. B., Watanabe H., Kachko A., Mihalik K., Virata-Theimer M.L., Alter H.J., Feinstone S., Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity // Proc. Natl. Acad. Sci. USA. -2009. -Vol. 106, N 18. -P. 537-541.
The authors declare that there are no conflicts of interest present.